Some 675 jobs are to be created following massive investment in the biopharmaceutical and software sectors in Cork, Dublin, and Galway.
Of that number, up to 500 positions will be generated in Cork as GE Healthcare invests €150m in four factories at a new biopharma campus.
In the short term, another 800 people will be employed in preparatory site works and construction at the new GE biopark.
Elsewhere, Oneview Healthcare software company is recruiting 50 staff in Dublin.
Global biopharma company, Mallinckrodt announced another 75 jobs at its Blanchardstown office in Dublin. Forty of the jobs will be in research and development while 35 will operate in other functions at the site.
Meanwhile, MathWorks, which makes mathematical software for research and development, will create 50 sales and services jobs in Galway.
The mayor of Cork, Seamus McGrath, and the chief executive of Cork County Council, Tim Lucey, described the GE Healthcare announcement as a “significant win for industry in the Cork region and an endorsement of Cork”.
The factories in Ringaskiddy will manufacture next-generation biopharmaceuticals and 100 of the jobs will be with GE Healthcare while the remaining 400 will be with other biopharma companies.
These companies are likely to be both Irish and international but their names have yet to be revealed, said David Radspinner, GE Healthcare BioPark general manager.
Amongs the products to be made at the Cork site are monoclonal antibodies. The 500 jobs will be high-end advanced manufacturing roles including engineering, quality control, environmental health and safety, and management positions.
The hiring process will begin next year according to Mr Radspinner but the bulk of the positions will not become operational until 2018.
The four new buildings at the IDA’s Loughbeg site in Ringaskiddy will be pre-fabricated as this will ensure savings of 25-30% on a traditional build. The construction phase, subject to planning approvals, is expected to begin in mid- 2017.
Cork Chamber of Commerce CEO Conor Healy said the decision to establish a manufacturing campus in Ringaskiddy was testament to the strength and success of the biopharmaceutical sector in Cork, as well as the track record of GE’s existing operation in Carrigtwohill.
To further develop biopharma manufacturing skills and expertise in Ireland, GE and the National Institute for Bioprocessing Research and Training (NIBRT) also announced plans to create a NIBRT-GE Single-use Centre of Excellence at NIBRT’s Dublin facility.
NIBRT expects to train up to 1,500 bioprocessing professionals annually on next-generation biologic manufacturing technologies. These exceptional technologies for biopharma manufacturing will be used in GE BioPark Cork’s manufacturing facilities.
The GE BioPark Cork will be a GE-managed campus and the four KUBio modular factories will be owned by independent biopharma companies manufacturing proprietary medicines.
Minister for Enterprise Mary Mitchell O’Connor said that biopharma is one of the “fastest growing sectors” and “makes a huge contribution to the Irish economy”.
Biopharma and software sector jobs
© Irish Examiner Ltd. All rights reserved